Medicare Fee Schedule Cuts Raise the Stakes for Revenue Cycle Performance

When reimbursement declines, protecting every earned dollar becomes a strategic priority.

Healthcare providers continue to face increasing financial pressure as proposed Medicare payment changes threaten already narrow operating margins. Pathology practices and laboratories performing related services are particularly vulnerable because even a relatively small reduction in reimbursement can become significant when applied across high-volume codes.

 

A Few Dollars Per Case Can Become Hundreds of Thousands

Consider CPT 88305, one of the most frequently performed surgical pathology services.

The current 2026 Medicare national unadjusted global payment is approximately $70.18 per unit. Using a proposed reduction of approximately 4% as an illustration, reimbursement would fall to approximately $67.37.

For a pathology group performing approximately 100,000 units of 88305 annually, a $2.81 reduction per unit represents approximately $281,000 less reimbursement in a single year—without performing one fewer service.

And that is only the impact of the fee schedule. What happens when additional revenue is lost to denials, underpayments, missed appeals, timely filing, incorrect payer processing, documentation issues, or preventable billing errors?

 

When Rates Go Down, Revenue Leakage Matters More

Providers may have limited control over Medicare fee schedule changes. They have considerably more control over how effectively they protect the reimbursement that remains. When reimbursement is compressed, organizations have less room to absorb preventable revenue loss. Every denied, underpaid, incorrectly processed, or unnecessarily written-off claim becomes more significant.

This makes visibility across the revenue cycle essential.

Organizations should know:

• Why claims are being denied and which payers are driving those denials.
• Whether contractual reimbursement is being received correctly.
• Which denials are appealed versus adjusted or written off.
• Appeal success rates and dollars recovered.
• Whether recurring denial trends are being corrected upstream.
• Whether payer policies and reimbursement changes are actively monitored.
• Whether billing performance is measured against meaningful KPIs.

 

Denial Management Must Become Denial Prevention

Strong denial management is not simply about working a claim after it denies. Organizations should use denial data to identify trends, determine root causes, and prevent the same problem from affecting the next 100 (or 1,000) claims.

The same applies to appeals. A successful appeal should do more than recover one payment. It should provide information that improves future documentation, coding, billing workflows, payer escalation, and contracting strategy.

 

All Hands-on Deck

Fee schedule pressure makes effective revenue cycle management more important, not less.

Clinical teams, coding, billing, operations, credentialing, contracting, compliance, finance, and leadership all play a role in protecting revenue. Organizations need the visibility to understand where revenue is being lost and the accountability to do something about it.

 

We Ask the Questions So You Don’t Have To.

Is your billing team identifying denial trends, or simply working individual claims? Are appeals being tracked through resolution? Are underpayments being identified? Are payer policies being monitored? Are recurring issues being escalated?

And most importantly: Do you have the visibility to know?

When reimbursement is declining, organizations cannot afford to leave earned revenue behind.

Contact Lighthouse Lab Services today for a complimentary consultation with our RCM Team to learn how we can strengthen your revenue cycle and recover what you’ve earned.

Protect the revenue you have earned before accepting that it is lost.

 

Sharing is caring!